6 This involvement of incretin hormones in people with type 2 diabetes contributed to the development of GLP-1 and GLP-1/GIP RAs, which mimic the naturally occurring incretin hormones
We were early to offer GLP 1 and GIP and have treated hundreds of patients
GLP-1 receptor agonists and other treatments discussed are prescription medications that should only be used under the guidance and supervision of a qualified healthcare professional
Seek urgent medical attention (contact 111 or attend A&E) if you develop: Severe, sudden-onset headache ("thunderclap" pattern) unlike any previous headache Headache with fever, rash, or altered consciousness Persistent vomiting preventing fluid intake or medicine absorption Visual changes including double vision, blind spots, or temporary vision loss Signs of severe dehydration (dark urine, dizziness on standing, reduced urination) Symptoms suggesting pancreatitis (severe upper abdominal pain radiating to the back) Symptoms suggesting gallbladder problems (right upper abdominal pain, fever, yellowing of skin/eyes) Your healthcare provider needs to assess whether headaches represent a straightforward medicine side effect or indicate a more complex issue
21 Radioligand-binding studies have shown high densities of GLP-1 receptors in the lateral septum, the subfornical organ, the thalamus, the hypothalamus, the interpenduncular nucleus, the posterodorsal tegmental nucleus, the area postrema (AP), the inferior olive and the nucleus tractus solitarius (NTS)
Retatrutide's Phase 3 trials (the TRIUMPH program) are still ongoing, and direct head-to-head data between the two drugs does not yet exist
